Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregnenolone and DHEA for Chronic Low Back Pain in US Military Veterans
NCT05935761Phase 2Not yet recruiting
- Sponsor
- VA Office of Research & Development
- Start
- Dec 2026
- Primary completion
- Oct 2029
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 2 trial of pregnenolone, dehydroepiandrosterone in chronic low back pain (CLBP), sponsored by VA Office of Research & Development. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
pregnenolonedehydroepiandrosterone
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT05935761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05935761.